MinichMacGregor Wealth Management’s NeoGenomics NEO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-300
Closed -$2.77K 438
2022
Q4
$2.77K Buy
+300
New +$2.8K ﹤0.01% 545
2018
Q4
Sell
-300
Closed -$4K 349
2018
Q3
$4K Hold
300
﹤0.01% 408
2018
Q2
$4K Hold
300
﹤0.01% 405
2018
Q1
$2K Hold
300
﹤0.01% 429
2017
Q4
$2K Hold
300
﹤0.01% 419
2017
Q3
$3K Hold
300
﹤0.01% 381
2017
Q2
$2K Hold
300
﹤0.01% 390
2017
Q1
$2K Hold
300
﹤0.01% 384
2016
Q4
$2K Hold
300
﹤0.01% 384
2016
Q3
$2K Hold
300
﹤0.01% 381
2016
Q2
$2K Hold
300
﹤0.01% 366
2016
Q1
$2K Hold
300
﹤0.01% 358
2015
Q4
$1K Buy
+300
New +$2.2K ﹤0.01% 355

Other funds holding NEO

MinichMacGregor Wealth Management's NEO Position: Q1 2023 in Review

MinichMacGregor Wealth Management sold out of NeoGenomics (NEO) in Q1 2023, closing a stake of 300 shares — an estimated $2.77K sold.

MinichMacGregor Wealth Management first reported a position in NEO in Q4 2015 and held it in 13 quarters. The position peaked at $4K in Q3 2018. 256 funds tracked by Wall St. Rank hold NEO as of Q1 2023.

  • MinichMacGregor Wealth Management reported no remaining NeoGenomics position as of Q1 2023 after selling out during the quarter.
  • MinichMacGregor Wealth Management sold 300 NeoGenomics shares in Q1 2023, an estimated $2.77K.
  • MinichMacGregor Wealth Management first reported a position in NeoGenomics in Q4 2015 and held it in 13 quarters.
  • MinichMacGregor Wealth Management's NeoGenomics position peaked at $4K in Q3 2018.
  • 256 funds tracked by Wall St. Rank held NeoGenomics as of Q1 2023.

Based on MinichMacGregor Wealth Management's 13F filing for Q1 2023, filed 19 Apr 2023.